Even with a variety of treatment schedules, TILs and colXα1 have strong predictive power for chemoresponse suggesting that they are general factors for NAC responsiveness in ER+/HER2+ breast tumors and further study of colXα1 and other collagens as predictive markers is warranted. The gene discussed is ESR1; the disease is breast neoplasm.